| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.084 | 19.186 | 19.174 | 31.721 | 58.277 | 25.423 | 54.230 | 33.926 | 29.468 | 3.482 |
| Total Income - EUR | 5.084 | 19.186 | 19.174 | 31.726 | 58.281 | 25.426 | 54.282 | 33.930 | 29.470 | 3.483 |
| Total Expenses - EUR | 15.426 | 13.309 | 17.859 | 23.384 | 32.208 | 23.147 | 34.005 | 38.324 | 31.764 | 11.223 |
| Gross Profit/Loss - EUR | -10.342 | 5.877 | 1.315 | 8.342 | 26.073 | 2.278 | 20.278 | -4.394 | -2.294 | -7.740 |
| Net Profit/Loss - EUR | -10.494 | 5.491 | 1.124 | 8.027 | 25.491 | 2.045 | 19.736 | -4.733 | -2.588 | -7.845 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Implantomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.620 | 5.032 | 5.289 | 10.869 | 10.260 | 9.552 | 7.171 | 5.017 | 3.169 | 1.787 |
| Current Assets | 67 | 3.822 | 11.727 | 13.132 | 17.316 | 8.838 | 18.110 | 9.686 | 13.723 | 7.458 |
| Inventories | 23 | 18 | 0 | 0 | 3 | 3.311 | 0 | 0 | 0 | 20 |
| Receivables | 0 | 711 | 699 | 859 | 852 | 0 | 1.200 | 1.624 | 11.681 | 8 |
| Cash | 44 | 3.093 | 11.028 | 12.273 | 16.461 | 5.527 | 16.910 | 8.061 | 2.042 | 7.430 |
| Shareholders Funds | -10.449 | -4.849 | -3.643 | 4.451 | 25.541 | 15.476 | 23.123 | 5.515 | 2.910 | -4.951 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.136 | 13.703 | 20.659 | 19.550 | 2.034 | 2.914 | 2.159 | 9.188 | 13.982 | 14.197 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Implantomed Srl